Kodiak Sciences (KOD) Shares Outstanding (2016 - 2026)
Kodiak Sciences (KOD) reported Shares Outstanding of $62.2 million for Q1 2026, up 17.83% on a YoY basis from $52.8 million in Q1 2025, and up 0.64% quarter-over-quarter from $61.8 million in Q4 2025.
Kodiak Sciences (KOD) Shares Outstanding (2016 - 2026) Analysis & Trends
Kodiak Sciences has reported Shares Outstanding for 11 years, with the latest figure at $62.2 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding rose 17.83% year-over-year to $62.2 million; the trailing twelve-month figure through Mar 2026 stood at $62.2 million (up 17.83% YoY), and the FY2025 full-year result was $61.8 million, up 17.13% from the prior year.
- Shares Outstanding for Q1 2026 stood at $62.2 million, up from $61.8 million in the prior quarter.
- The five-year high for Shares Outstanding was $62.2 million in Q1 2026, with the low at $51.9 million in Q1 2022.
- Historically, Shares Outstanding has averaged $53.6 million across 5 years, with a median of $52.5 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding increased 0.3% — and 2026, when it advanced 17.83%.
- Kodiak Sciences' Shares Outstanding stood at $52.3 million in 2022, then advanced by 0.33% to $52.5 million in 2023, then grew by 0.42% to $52.7 million in 2024, then advanced by 17.13% to $61.8 million in 2025, then climbed by 0.64% to $62.2 million in 2026.
- The last three Shares Outstanding figures came in at $62.2 million (Q1 2026), $61.8 million (Q4 2025), and $53.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 91.57 Bn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Kodiak Sciences | 1.92 Bn | 1.92 Bn | - | 62.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.16 Mn |
| Mar 31, 2026 | 62.16 Mn |
| Mar 31, 2026 | 62.16 Mn |
| Mar 31, 2026 | 62.16 Mn |
| Mar 31, 2026 | 62.16 Mn |
| Mar 31, 2026 | 62.16 Mn |
| Mar 31, 2026 | 62.16 Mn |
| Mar 31, 2026 | 62.16 Mn |
| Dec 31, 2025 | 61.76 Mn |
| Dec 31, 2025 | 61.76 Mn |
| Dec 31, 2025 | 61.76 Mn |
| Dec 31, 2025 | 61.76 Mn |
| Dec 31, 2025 | 61.76 Mn |
| Dec 31, 2025 | 61.76 Mn |
| Dec 31, 2025 | 61.76 Mn |
| Dec 31, 2025 | 61.76 Mn |
| Sep 30, 2025 | 53.00 Mn |
| Sep 30, 2025 | 53.00 Mn |
| Sep 30, 2025 | 53.00 Mn |
| Sep 30, 2025 | 53.00 Mn |